Milagen Overview

  • Founded
  • 1997
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Milagen General Information


Developer of tissue-based immunodiagnostic products designed to detect and offer efficient treatment for cancer. The company's products help to fulfill unmet clinical needs, as well as develop biomarkers and immunoassays for the diagnosis and management of major cancers, enabling healthcare professionals to prevent and detect cancer faster and ensure speedy recovery of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Healthcare Technology Systems
Primary Office
  • 1255 Park Avenue
  • Suite B
  • Emeryville, CA 94608
  • United States
+1 (510) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Milagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 01-Mar-2021 000.00 Completed Generating Revenue
8. Grant 01-Jan-2010 000.00 Completed Generating Revenue
7. Grant 01-Jun-2008 00000 000.00 Completed Generating Revenue
6. Grant 01-Sep-2006 00000 000.00 Completed Generating Revenue
5. Grant 01-Sep-2005 00000 000.00 Completed Generating Revenue
4. Grant 01-Sep-2003 00000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Jun-2003 00.000 000.00 Completed Generating Revenue
2. Later Stage VC (Series B) 15-Mar-2002 $3.3M $6.56M Completed Generating Revenue
1. Early Stage VC (Series A) 14-Apr-2001 $3.27M $3.27M Completed Startup
To view Milagen’s complete valuation and funding history, request access »

Milagen Executive Team (4)

Name Title Board Seat Contact Info
Moncef Jendoubi Ph.D Founder, President, Chief Scientific Officer & Chief Executive Officer
Heinz Bodenmueller Ph.D Vice President, Business Development and Strategy
Alfredo Quattrone Ph.D Vice President of Regulatory Affairs
Rosaura Valle Ph.D Vice President, Operations & Strategic Alliances
To view Milagen’s complete executive team members history, request access »

Milagen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The National Institute of Diabetes and Digestive and Kidney Diseases Government 000 0000 000000 0
National Cancer Institute Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Milagen’s complete investors history, request access »